News ArchivesRead News
Variants in three estrogen-related genes linked to Parkinson’s disease in women
Wednesday November 22, 2006
11/20/06(Mayo Clinic) - Researchers at Mayo Clinic have discovered a possible connection between increased risk for Parkinson’s disease and variants in three genes that control estrogen production and activity in the body.
“We and other investigators have found evidence that estrogen helps protect women from developing Parkinson’s," says Walter Rocca, at Mayo Clinic and lead study investigator. " So, a gene variant that would decrease estrogen production or activity would put those women at greater risk for the disease."
The study associated variants in the following three genes with development of Parkinson’s: estrogen receptor 1 gene ( ESR1 ); estrogen receptor 2 gene ( ESR2 ); and PR domain-containing protein 2 gene ( PRDM2 ).
" The gene variants are not a defect or a problem in and of themselves -- they are part of human differences, simply differences across people," says Rocca. " These differences make one subgroup of the population more susceptible to a disease like Parkinson’s. However, sometimes the genetic variant is a weak risk factor, and the disease only manifests if another risk factor is present, such as a particular diet, physical exercise, taking certain medications or a medical event."
The study was conducted using a database from a previous study of the entire human genome for genes linked to Parkinson’s. For the new study, the Mayo Clinic investigators examined several genes for variants in 172 women who had Parkinson’s and 229 women who did not have the disease.
Rocca explains that some genetic variants the study pinpointed for association with Parkinson’s are quite common, affecting 10 to 20 percent of the female population. As women are not routinely tested for these gene variations, however, those affected would be unaware, he says.
" If the findings of this study are replicated and confirmed, the hope is to use these variants to predict the risk of disease using a simple blood test," says Rocca. He explains that the test would be particularly useful for women and their physicians before deciding to conduct an elective ovariectomy, surgical removal of the ovaries, because a combination of estrogen-reducing factors could amplify a woman’s risk for Parkinson’s.
Recent NewsJul 20 - Parkinson’s DREAM Challenge Uses Mobile Sensor Data to Monitor Health Based on Movement
Jul 19 - What Young-onset Parkinson’s Can Look Like
Jul 7 - Parkinson’s Patients Have a Higher Risk of Developing Melanoma — and Vice Versa, Study Finds
Jun 27 - The rogue protein behind Parkinson’s disease may also protect your gut
Jun 26 - Do Statins Increase Risk of Parkinson’s Disease? Some Researchers Think So
Jun 22 - A Confused Immune System Could Be Behind Parkinson's Disease
Jun 21 - Predicting cognitive deficits in people with Parkinson’s disease
Jun 20 - Gym offers classes in noncontact boxing for Parkinson’s patients
Jun 19 - Human Limitations Could Prevent Us From Advancing in Science. AI Could Help.
Jun 13 - Brain Cell Transplants Are Being Tested Once Again For Parkinson's
Jun 12 - Smell Test May Sniff Out Oncoming Parkinson's and Alzheimer's
Jun 8 - Smartphones Track Motor Function in Parkinson's Disease
Jun 8 - GKC Enrolls First Patient in Personal KinetiGraph Trial as Part of NPF’s Parkinson’s Outcomes Project
Jun 8 - Low-fat dairy intake may raise Parkinson's risk
Jun 6 - Patient Voices: Parkinson's Disease
Jun 1 - World-First Trials Have Been Launched to Treat Parkinson's And Blindness With Embryonic Stem Cells
Jun 1 - LIFE Shared This Remarkable Parkinson's Disease Story in 1959.
May 24 - Survival Rates Differ Widely in Parkinson's, MSA, Lewy Bodies
May 22 - Discovery may offer hope to Parkinson's disease patients
May 15 - Study offers answers on life expectancy for people with Parkinson's disease, Lewy body dementia